Methods of using substituted tetracycline compounds to modulate RNA

Details for Australian Patent Application No. 2003287217 (hide)

Owner Paratek Pharmaceuticals, Inc.

Inventors Jones, Graham; Levy, Stuart B.; Nelson, Mark L.; Draper, Michael

Agent Watermark

Pub. Number AU-B-2003287217

PCT Number PCT/US2003/0339

PCT Pub. Number WO2004/038000

Priority 60/421,248 24.10.02 US

Filing date 24 October 2003

Wipo publication date 13 May 2004

Acceptance publication date 4 March 2010

International Classifications

A61K 31/65 (2006.01) - Tetracyclines

Event Publications

1 April 2004 Complete Application Filed

  Priority application(s): 60/421,248 24.10.02 US

17 June 2004 Application Open to Public Inspection

  Published as AU-B-2003287217

4 March 2010 Application Accepted

  Published as AU-B-2003287217

1 July 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003287218-Substituted tetracycline compounds for the treatment of malaria

2003287216-GB VIRUS C AND METHODS OF TREATING VIRAL INFECTIONS